Knee arthropathy secondary to Mycobacterium scrofulaceum.
D001170:Arthritis, Infectious / Q000188:drug therapy / Q000382:microbiology*; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D007719:Knee Joint / Q000382:microbiology*; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000150:complications* / Q000188:drug therapy; D010653:Phenylbutazone / Q000627:therapeutic use; D013582:Synovial Fluid / Q000382:microbiology
D007612:Kanamycin; D010653:Phenylbutazone; D004318:Doxycycline; D007213:Indomethacin